• Profile
Close

Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients

Liver International Dec 05, 2018

Maasoumy B, et al. - In patients with hepatitis C virus (HCV) genotype 1 infection treated with ledipasvir (LDV) and sofosbuvir (SOF) ± ribavirin (RBV) in a large real-world cohort, researchers studied the frequency and predictive value of detectable and quantifiable HCV RNA results at the end of antiviral treatment (EOT). In this real-world study, the frequency of detectable HCV RNA in EOT was 7% for 471 patients. In addition, 3% of the patients even had quantifiable viral load at the EOT. When highly sensitive HCV RNA assays are used, detectable and even quantifiable results of HCV RNA are quite common. As SVR rates remain high in these patients, treatment prolongation was not indicated.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay